- You can view the full Akorn Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Cramer is only blessing Box and Akorn for speculation.
A year ago the market was in a massive tailspin. It survived and has been going up ever since, Cramer says.
Here are Friday's top research calls, including downgrades for FireEye and Teva Pharmaceuticals, and upgrades for Kraft Heinz and U.S. Steel.